Baclofen ICD-10-CM Drugs Index. The ICD-10-CM Drugs Index is designed to allow medical coders to look up various medical terms and connect them with the appropriate ICD codes. There are 0 terms under the parent term 'Baclofen' in the ICD-10-CM Drugs Index.
All patients receiving intrathecal baclofen therapy are potentially at risk for withdrawal. Early symptoms of baclofen withdrawal may include return of baseline spasticity, pruritus, hypotension, and paresthesias.
F19.939 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Other psychoactive substance use, unsp with withdrawal, unsp The 2022 edition of ICD-10-CM F19.939 became effective on October 1, 2021.
Abrupt discontinuation of intrathecal baclofen, regardless of the cause, has resulted in sequelae that include high fever, altered mental status, exaggerated rebound spasticity, and muscle rigidity, that in rare cases has advanced to rhabdomyolysis, multiple organ-system failure and death.
Lioresal ® Intrathecal (baclofen injection) is a muscle relaxant and antispastic that is indicated for use in the management of severe spasticity of cerebral or spinal origin.
It is mandatory that all patients, caregivers, and treating physicians receive adequate information regarding the risks of the mode of treatment.
The most frequent drug adverse events vary by indication but include: hypotonia (34.7%), somnolence (20.9%), headache (10.7%), convulsion (10.0%), dizziness (8.0%), urinary retention (8.0%), nausea (7.3%), and paresthesia (6.7%). Dosing and programming errors may result in clinically significant overdose or withdrawal.
There are no adequate and well controlled studies in pregnant women. Lioresal ® Intrathecal should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.